MarketScale
‹ Back to Industries

Sciences

Next Big European IPO Is In Medical Diagnostics

Siemens AG’s big IPO is in the pipeline and due to begin trading March 16, 2018. They are making a big bet on selling equipment that analyzes blood and other medical samples. Ironically it’s a segment of their business that hasn’t enjoyed much success, and comes at the same time they launched a new diagnostics…

By Sciences · March 16, 2018, 2:39 AM UTC
Share

Key takeaways

01

Siemens AG’s big IPO is in the pipeline and due to begin trading March 16, 2018.

02

They are making a big bet on selling equipment that analyzes blood and other medical samples.

03

Ironically it’s a segment of their business that hasn’t enjoyed much success, and comes at the same time they launched a new diagnostics…

Siemens AG’s big IPO is in the pipeline and due to begin trading March 16, 2018. They are making a big bet on selling equipment that analyzes blood and other medical samples. Ironically it’s a segment of their business that hasn’t enjoyed much success, and comes at the same time they launched a new diagnostics brand (Atellica) that is meant to replace older products that are also less than successful.  Competitors Roche Holdings and Abbott Laboratories continue to outperform Siemens, so a lot is riding on this IPO bet.

Read more at Bloomberg

About the author

S
Sciences

Free workspace

You just read one expert. Imagine publishing yours.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social, at scale. No credit card, no demo required.

Request invite →Book a demoNPS +73 · 1,000+ creators · 38+ countries

Explore More Sciences Insights

Discover expert perspectives across the full Sciences vertical.

Browse Sciences Hub

About the Expert

S
Sciences